Xunfei Healthcare Technology Co., Ltd. (HKG:2506)
Hong Kong · Delayed Price · Currency is HKD 73.40
-3.25 (-4.24%)
Aug 24, 2026, 4:08 PM HKT
HKG:2506 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,063 | 914.99 | 733.98 | 556.13 | 471.86 | 372.45 | |
Revenue Growth | 32.27% | 24.66% | 31.98% | 17.86% | 26.69% | - |
Cost of Revenue | 518.67 | 453.35 | 329.9 | 241.47 | 241.19 | 184.72 |
Gross Profit | 543.89 | 461.64 | 404.08 | 314.65 | 230.67 | 187.73 |
Selling, General & Admin | 299.73 | 308.59 | 287.99 | 275.62 | 269.27 | 160 |
Research & Development | 282.08 | 245.26 | 271.89 | 263.96 | 241.58 | 159.79 |
Operating Expenses | 616.35 | 588.39 | 572.27 | 545.41 | 519.6 | 319.94 |
Operating Income | -72.46 | -126.75 | -168.19 | -230.75 | -288.93 | -132.21 |
Interest Expense | -11.08 | -11.44 | -6.14 | -1.21 | -0.59 | -2.9 |
Interest & Investment Income | 11.15 | 11.15 | 6.42 | 7.96 | 3.14 | 1.81 |
Earnings From Equity Investments | -8.4 | -2.86 | - | - | - | - |
Currency Exchange Gain (Loss) | 5.47 | 5.47 | -0 | - | - | - |
Other Non Operating Income (Expenses) | 22.26 | 28.36 | -4.43 | 36.22 | 39.55 | 22.47 |
EBT Excluding Unusual Items | -53.06 | -96.07 | -172.34 | -187.79 | -246.84 | -110.83 |
Gain (Loss) on Sale of Investments | -10.38 | 0.12 | 0.32 | 0.9 | 2.73 | - |
Gain (Loss) on Sale of Assets | -0.04 | -0.04 | -0.02 | -0.03 | 0.01 | -0.14 |
Other Unusual Items | - | - | 0.03 | - | - | - |
Pretax Income | -63.48 | -95.99 | -172.02 | -186.92 | -244.1 | -110.97 |
Income Tax Expense | -31.88 | -30.22 | -34.38 | -32.69 | -35.51 | -21.57 |
Earnings From Continuing Operations | -31.59 | -65.77 | -137.64 | -154.22 | -208.6 | -89.4 |
Minority Interest in Earnings | -18.41 | 0.98 | 5.04 | 9.38 | 19.2 | 5.69 |
Net Income | -50.01 | -64.79 | -132.6 | -144.84 | -189.4 | -83.71 |
Net Income to Common | -50.01 | -64.79 | -132.6 | -144.84 | -189.4 | -83.71 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 121 | 121 | 114 | 111 | 111 | 93 |
Shares Outstanding (Diluted) | 121 | 121 | 114 | 111 | 111 | 93 |
Shares Change | 2.80% | 6.16% | 2.47% | 0.11% | 18.89% | - |
EPS (Basic) | -0.41 | -0.54 | -1.16 | -1.30 | -1.71 | -0.90 |
EPS (Diluted) | -0.41 | -0.54 | -1.16 | -1.30 | -1.71 | -0.90 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -97.68 | -85.28 | -142.2 | -325.13 | -119.92 | -58.74 |
Free Cash Flow Per Share | -0.81 | -0.70 | -1.25 | -2.93 | -1.08 | -0.63 |
Gross Margin | 51.19% | 50.45% | 55.05% | 56.58% | 48.88% | 50.40% |
Operating Margin | -6.82% | -13.85% | -22.91% | -41.49% | -61.23% | -35.50% |
Profit Margin | -4.71% | -7.08% | -18.07% | -26.05% | -40.14% | -22.48% |
Free Cash Flow Margin | -9.19% | -9.32% | -19.37% | -58.46% | -25.41% | -15.77% |
EBITDA | -43.89 | -94.79 | -136.18 | -204.54 | -250.68 | -102.64 |
EBITDA Margin | -4.13% | -10.36% | -18.55% | -36.78% | -53.13% | -27.56% |
D&A For EBITDA | 28.57 | 31.96 | 32.01 | 26.21 | 38.26 | 29.57 |
EBIT | -72.46 | -126.75 | -168.19 | -230.75 | -288.93 | -132.21 |
EBIT Margin | -6.82% | -13.85% | -22.91% | -41.49% | -61.23% | -35.50% |
Advertising Expenses | - | - | - | - | 8.14 | 3.44 |